Uni-Bio Science Group Limited (HK690) is an innovative biopharmaceutical enterprise listed on the Main Board of The Stock Exchange of Hong Kong. Its core business includes the R&D, manufacturing, and sales of biologic and chemical pharmaceutical products, with a focus on the research, development, and commercialization of biopharmaceuticals.
Focus Areas
Notable Investments
